Jacqueline Claire Lupo
Director Ejecutivo en LOPHOS HOLDINGS INC. .
Fortuna: 440 000 $ al 31/05/2024
Cargos activos de Jacqueline Claire Lupo
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| LOPHOS HOLDINGS INC. | Director/Miembro de la Junta | 23/12/2021 | - |
| Director Ejecutivo | 23/12/2021 | - | |
Lophos Pharmaceuticals Corp.
 Lophos Pharmaceuticals Corp. BiotechnologyHealth Technology Part of Lophos Holdings, Inc., Lophos Pharmaceuticals Corp. is a Canadian biosciences company that specializes in peyote cultivation, research, and sale. The company is also licensed to possess, sell/provide, send, transport and deliver controlled substances covered by their controlled substances dealers license (CSDL), namely mescaline, psilocin, psilocybin, LSD, DMT, and ketamine, as well as produce mescaline, psilocin, and psilocybin. Lophos Pharmaceuticals was acquired by Greenridez 2.0 Acquisitions Corp. on January 21, 2022. | Director/Miembro de la Junta | 01/01/2021 | - |
| Director Ejecutivo | 01/09/2021 | - | |
| Fundador | 01/01/2021 | - | |
| Presidente | 01/09/2021 | - | |
| Northern Green Canada, Inc. | Corporate Officer/Principal | - | - |
Historial de carrera de Jacqueline Claire Lupo
Antiguos cargos conocidos de Jacqueline Claire Lupo.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Canalytica Corp. | Fundador | - | - |
Estadísticas
Internacional
| Canadá | 4 |
| 2 |
Operativa
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sectorial
| Health Technology | 2 |
| Consumer Non-Durables | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
| Lophos Holdings, Inc. | |
Lophos Pharmaceuticals Corp.
Lophos Pharmaceuticals Corp. BiotechnologyHealth Technology Part of Lophos Holdings, Inc., Lophos Pharmaceuticals Corp. is a Canadian biosciences company that specializes in peyote cultivation, research, and sale. The company is also licensed to possess, sell/provide, send, transport and deliver controlled substances covered by their controlled substances dealers license (CSDL), namely mescaline, psilocin, psilocybin, LSD, DMT, and ketamine, as well as produce mescaline, psilocin, and psilocybin. Lophos Pharmaceuticals was acquired by Greenridez 2.0 Acquisitions Corp. on January 21, 2022. | Health Technology |
| Northern Green Canada, Inc. | Consumer Non-Durables |
| Canalytica Corp. |
